Document


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): June 12, 2018

eHealth, Inc.
(Exact Name of Registrant as Specified in its Charter)

 
 
 
Delaware
001-33071
56-2357876
(State or other jurisdiction of
(Commission File Number)
(I.R.S. Employer
incorporation)
 
Identification No.)

440 EAST MIDDLEFIELD ROAD
MOUNTAIN VIEW, CALIFORNIA 94043
(Address of principal executive offices)    (Zip Code)

(650) 584-2700
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
 






Item 5.07
Submission of Matters to a Vote of Security Holders.

eHealth, Inc. held its annual meeting of stockholders (the “Annual Meeting”) on June 12, 2018. A total of 17,520,189 shares of eHealth’s common stock were represented at the Annual Meeting in person or by proxy, or 92.29% of the total shares entitled to vote.

Summarized below are the final voting results for each proposal submitted to a vote of the stockholders at the Annual Meeting:

Proposal 1 Election of Directors. Our stockholders voted to re-elect two Class III directors, Jack L. Oliver, III and Ellen O. Tauscher, to serve for a term of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal, with voting results as follows:

Name
 
      Votes For
 
Votes Withheld
 
Broker Non-Votes
Jack L. Oliver, III
 
12,868,120
 
1,973,994
 
2,678,075
Ellen O. Tauscher
 
14,080,749
 
761,365
 
2,678,075

Proposal 2 Ratification of the Appointment of Independent Registered Public Accounting Firm.  Our stockholders voted to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018 with voting results as follows:

      Votes For
 
Votes Against
 
  Abstain
 
Broker Non-Votes
17,272,002
 
244,403
 
3,784
 
0

Proposal 3 A Vote to Approve, on an Advisory Basis, the Compensation of our Named Executive Officers. Our stockholders approved the compensation of our chief executive officer and our other Named Executive Officers named in the proxy statement for the Annual Meeting with voting results as follows:

      Votes For
 
Votes Against
 
  Abstain
 
Broker Non-Votes
13,470,847
 
1,298,350
 
81,917
 
2,678,005


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
EHEALTH, INC.
 
 
 
 
 
 
By:
/s/ Scott Giesler
 
 
 
 
 
 
Scott Giesler
 
 
 
SVP, General Counsel
Date: June 14, 2018